In the published article, there was an error in affiliation 8. Instead of “Division of Early Drug Development, European Institute of Oncology, Milan, Italy”, it should be “Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Generali, D., Berardi, R., Caruso, M., Cazzaniga, M., Garrone, O., Minchella, I., et al. (2024). Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions(Front. Oncol., (2023), 13, (1249160), 10.3389/fonc.2023.1249160) [Altro] [10.3389/fonc.2024.1369562].
Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions(Front. Oncol., (2023), 13, (1249160), 10.3389/fonc.2023.1249160)
Cazzaniga M.;
2024
Abstract
In the published article, there was an error in affiliation 8. Instead of “Division of Early Drug Development, European Institute of Oncology, Milan, Italy”, it should be “Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
| File | Dimensione | Formato | |
|---|---|---|---|
|
fonc-14-1369562.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
218.22 kB
Formato
Adobe PDF
|
218.22 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
